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Highly puriﬁed glycosylphosphatidylinositols from
Trypanosoma cruzi are potent proinﬂammatory
agents
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tion. Ingestion of bloodstream form trypomastigotes by aDaniela O.Proco´pio3, Luiz S.Silva4,
reduviid bug results in their differentiation to dividingAngela Mehlert1, Luiz R.Travassos4,
epimastigote forms that subsequently differentiate intoRicardo T.Gazzinelli5 and
non-dividing metacyclic forms, thus completing the lifeMichael A.J.Ferguson1,6
cycle. The different life cycle stages of T.cruzi synthesize
common and stage-speciﬁc cell surface macromolecules1Division of Molecular Parasitology and Biological Chemistry,
Department of Biochemistry, University of Dundee, Dundee throughout the life cycle.
DD1 5EH, UK, 3Department of Biochemistry and Immunology, Macrophages are triggered by certain microbial com-
Universidade Federal de Minas Gerais, Belo Horizonte, MG, ponents to induce phagocytosis, microbicidal activity and4Discipline of Cell Biology, Department of Microbiology, Immunology
the release of cytokines, such as interleukin (IL)-12 andand Parasitology, Universidade Federal de Sa˜o Paulo, Sa˜o Paulo,
SP 0423-062 and 5Centro de Pesquisas Rene´ Rachou, Fundac¸a˜o other co-stimulatory cytokines, which are crucial for the
Oswaldo Cruz, Belo Horizonte, MG 30190-002, Brazil stimulation of innate immunity (Gazzinelli et al., 1993;
Vespa et al., 1994; Biron and Gazzinelli, 1995; Silva2Present address: Department of Parasitology, Biomedical Sciences
Institute, Universidade de Sa˜o Paulo, SP 05508-900, Brazil et al., 1995; Aliberti et al., 1996; Fearon and Locksley,
1996; Trinchieri and Scott, 1996). In addition, the early6Corresponding author
e-mail: m.a.j.ferguson@dundee.ac.uk stimulation of macrophages and natural killer (NK) cells
appears to have an important role in directing the develop-
Intracellular protozoan parasites are potent stimula- ment of cell-mediated immunity (CMI) (Hsieh et al.,
tors of cell-mediated immunity. The induction of 1993; Seder et al., 1993; Abbas et al., 1996; Fearon
macrophage proinﬂammatory cytokines by Trypano- and Locksley, 1996). During infection with T.cruzi, the
soma cruzi is considered to be important in controlling induction of parasite-speciﬁc CMI is likely to be involved
the infection and the outcome of Chagas’ disease. Here in at least two aspects of Chagas’ disease pathophysiology
we show that the potent tumour necrosis factor-α-, (Vespa et al., 1994; Fearon and Locksley, 1996; Brener
interleukin-12- and nitric oxide-inducing activities of and Gazzinelli, 1997). The ﬁrst is the control of parasite
T.cruzi trypomastigote mucins were recovered quanti- replication and its spread in the vertebrate host tissues.
tatively in a highly puriﬁed and characterized glycosyl- The second is the inﬂammatory reaction observed in the
phosphatidylinositol (GPI) anchor fraction of this infected host tissues, which is likely to be a major cause
material. The bioactive trypomastigote GPI fraction of cardiac tissue damage during the acute and chronic
was compared with a relatively inactive GPI fraction phases of the disease.
prepared from T.cruzi epimastigote mucins. The trypo- Relatively little is known about the protozoan parasite
mastigote GPI structures were found to contain addi- molecules that initiate the synthesis of pro-inﬂammatory
tional galactose residues and unsaturated, instead of cytokines and nitric oxide (NO) by macrophages. Recent
saturated, fatty acids in the sn-2 position of the alkyl- studies have suggested a role for glycosylphosphatidyl-
acylglycerolipid component. The latter feature is essen- inositol (GPI) anchors from Plasmodium falciparum
tial for the extreme potency of the trypomastigote (Schoﬁeld and Hackett, 1993; Schoﬁeld et al., 1996;
GPI fraction, which is at least as active as bacterial Tachado et al., 1996, 1997) and Trypanosoma brucei
endotoxin and Mycoplasma lipopeptide and, therefore, (Magez et al., 1998) in this process. However, no evidence
one of the most potent microbial proinﬂammatory of the biochemical purity of the P.falciparum GPIs was
agents known. provided, making estimates of their concentrations dubi-
Keywords: Chagas’ disease/cytokines/glycosylphospha- ous. Furthermore, the possibility of Mycoplasma lipopep-
tidylinositol/inﬂammation/nitric oxide tide (Mu¨hlradt et al., 1997) contamination (that has
confounded other studies into proinﬂammatory factors)
cannot be formally excluded. In the case of the T.brucei
GPI work, highly puriﬁed and structurally characterizedIntroduction fractions were used, but cytokine induction was only
seen when these molecules were used at micromolarThe protozoan parasite Trypanosoma cruzi is transmitted
concentrations that may not be physiologically relevant.to mammals in the faeces of the reduviid bug insect vector.
We have described previously the ability of GPI-The metacyclic trypomastigotes that enter the mammalian
anchored mucin-like glycoproteins from the trypo-host, via skin lesions and/or mucous membranes, invade
mastigote (but not the epimastigote or metacyclic) lifehost cells and differentiate into small amastigote forms
cycle stage of T.cruzi to trigger the synthesis of tumourthat replicate in the cytoplasm. Following differentiation
necrosis factor (TNF)-α, IL-12 and NO by mouse inﬂam-into non-dividing bloodstream form trypomastigotes, the
parasites escape and re-invade host cells (predominantly matory macrophages (Camargo et al., 1997a,b). The
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Fig. 1. Fractionation and bioactivity of T.cruzi GPI-anchored glycoconjugates. Octyl-Sepharose chromatograms of T.cruzi trypomastigote (A) and
epimastigote (B) glycoconjugate extracts from 1.5  1010 and 2.0  1010 cells, respectively. Aliquots of each fraction were presented to 106
thioglycollate-elicited, IFN-γ-primed, murine peritoneal macrophages and the amounts of TNF-α (d), IL-12(p40) (s) and NO (u) (measured as
nitrite) produced in 24 h were measured. Vertical bars indicate the molarity of the glycoconjugate used in each assay, based on the myo-inositol
content of each fraction eluted from the column. The data shown in (A) and (B) are representative of three different fractionation experiments. Peak
fractions were pooled as indicated and titrated for TNF-α- (C), IL-12(p40)- (D) and NO- (E) inducing activity. Trypomastigote-derived peak I and II
materials (d, s); epimastigote-derived peak I, II and III materials (u, m, n). The data shown in (C–E) are representative of three separate titration
experiments with three different sets of fractions. Each cytokine and NO determination was carried out in duplicate, and the error bars (where
visible) indicate the standard error of the mean.
present study was undertaken to isolate and deﬁne the Essentially all of the cytokine- and NO-inducing activity
of the trypomastigote preparation co-eluted with a peakactive component(s) of the T.cruzi trypomastigote mucins,
establish their purity and structure, compare their structure of myo-inositol-containing material (Figure 1A, peak II).
Another earlier eluting peak containing myo-inositol waswith similar yet relatively inactive material for T.cruzi
epimastigote and metacyclic forms, look directly for also observed (Figure 1A, peak I), but this material
had little or no NO- or cytokine-inducing activity. ThepossibleMycoplasma lipopeptide contamination and estab-
lish their potency in precise molar terms. A detailed equivalent preparation from epimastigotes produced three
myo-inositol-containing peaks (peaks I–III) that had littleknowledge of the structure–activity relationships of para-
site cytokine-inducing factors may provide insights into or no cytokine- or NO-inducing activity (Figure 1B).
The epimastigote peak III material was analysed bythe processes controlling the inﬂammatory responses
responsible for the immunopathology associated with electrospray-mass spectrometry (ES-MS) (data not shown)
and found to contain the previously described GPI-relatedmany protozoan parasite infections.
glycoinositol phospholipids (GIPLs) (De Lederkremer
et al., 1976, 1991; Mendonc¸a-Previato et al., 1983;Results Previato et al., 1990; Carreira et al., 1996) that are much
Puriﬁcation and analysis of T.cruzi trypomastigote less abundant in trypomastigotes (Golgher et al., 1993).
and epimastigote mucins The peak I and peak II fractions from the trypomastigote
We puriﬁed trypomastigote and epimastigote mucins from and epimastigote preparations were analysed by SDS–
Y strain T.cruzi as described before (Almeida et al., 1994; PAGE and silver staining (not shown), which revealed the
Serrano et al., 1995) and analysed the fractions eluting characteristic high and low apparent molecular weight
from the ﬁnal octyl-Sepharose chromatography step for mucins of these life cycle stages, respectively (Alves and
myo-inositol content, by selected ion-monitoring gas chro- Colli, 1975; Previato et al., 1985; Schenkman et al.,
matography–mass spectrometry (GC–MS) (Ferguson, 1993; Almeida et al., 1994; Camargo et al., 1997a). The
1993), and for the induction of TNF-α, IL-12 and NO trypomastigote peak I and II fractions also reacted strongly
when presented to interferon (IFN)-γ-primed C3H/HeJ with total serum and anti-α-galactosyl antibodies isolated
from patients with chronic Chagas’ disease (Almeidamouse macrophages (Camargo, 1997a,b) (Figure 1).
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Table I. Phosphatidylinositols released from puriﬁed T.cruzi GPI-anchored glycoconjugates by nitrous deamination
Pseudomolecular iona Octyl-Sepharose fraction (see Figure 1A and B) Lipid component of the PI moiety
[M-H]–
m/z Trypomastigote (%) Epimastigote (%)
I II I II III
557 95 11 29 13 2 1-O-(C16:0)lyso-alkylglycerol
571 trb 0 17 5 7 (C16:0)lyso-acylglycerol
599 tr 0 12 tr tr (C18:0)lyso-acylglycerol
627 tr 0 12 0 0 (C20:0)lyso-acylglycerol
655 tr 0 6 0 0 (C22:0)lyso-acylglycerol
778 0 0 0 0 6 ceramide, (C16:0)fatty acid-(C18:1)sphingosine
780 0 0 0 0 8 ceramide, (C16:0)fatty acid-(C18:0)sphinganine
795 5 37 24 77 16 1-O-(C16:0)alkyl-2-O-(C16:0)acylglycerol
819 tr 21 0 0 0 1-O-(C16:0)alkyl-2-O-(C18:2)acylglycerol
821 0 31 0 0 0 1-O-(C16:0)alkyl-2-O-(C18:1)acylglycerol
823 0 0 0 2 0 1-O-(C16:0)alkyl-2-O-(C18:0)acylglycerol
890 0 0 0 0 18 ceramide, (C24:0)fatty acid-(C18:1)sphingosine
892 0 0 0 3 43 ceramide, (C24:0)fatty acid-(C18:0)sphinganine
aOther minor pseudomolecular ion species that could not be characterized by ES-MS–CID-MS as inositolphospholipids were not included in this table.
btr  trace.
et al., 1991), which is synonymous with the presence of trypomastigote peak II mucins (Figure 2A–C). The puriﬁed
trypomastigote GPI anchors had essentially the sametrypomastigote mucins (Almeida et al., 1994).
Thephosphatidylinositol (PI)moieties of theGPI anchors speciﬁc activity (relative to myo-inositol content) as the
intact trypomastigote peak II mucins and, as expected, theof the puriﬁed trypomastigote and epimastigote mucins
(peaks I and II) and the epimastigote GIPLs (peak III) puriﬁed epimastigote GPI anchors had relatively little
activity. The puriﬁed GPI anchors were analysed bywere released by nitrous acid deamination and analysed
by ES-MS and ES-MS–collision-induced dissociation ES-MS (Figure 2D and E). Both preparations showed ion
clusters corresponding to doubly charged pseudomolecular(CID)-MS (Table I). These data were consistent with those
previously published for the epimastigote mucins (Previato ions. In the case of the epimastigote mucin GPI anchors,
the m/z values of these ions can be interpreted readily inet al., 1995; Serrano et al., 1995) andGIPLs (Previato et al.,
1990; De Lederkremer et al., 1991, 1993; Carreira et al., terms of the known primary structures and compositions
of these GPI anchors (Figures 2E and 5) (Previato et al.,1996) and trypomastigote mucins (Camargo et al., 1997a),
and further showed that the peak I fractions contained 1995; Serrano et al., 1995). Taking into account these
assignments, and the data on the PI molecular species inmainly lyso-PI species.
The trypomastigote and epimastigote peak materials Table I, the doubly charged ions of the trypomastigote
GPI anchors can also be interpreted (Figures 2D and 5).from Figure 1 were pooled separately, quantiﬁed by total
myo-inositol content and, using these values to estimate In essence, the epimastigote anchors contain 4–5 hexoses
and fully saturated alkylacyl-PI moieties, whereas thethe molarity of the fractions, titrated for the induction of
TNF-α, IL-12 and NO when presented to macrophages trypomastigote anchors contain 4–8 hexoses and mainly
unsaturated (C18:1 or C18:2) fatty acids in their(Figure 1C–E). The trypomastigote peak II material was
extremely active, giving signiﬁcant induction of TNF-α alkylacyl-PI moieties. The precise arrangement of the
hexoses in the trypomastigote mucins was not determined,and IL-12 at concentrations 30 pM, and signiﬁcant
induction of NO at the lowest concentration tested (2 pM). but it is reasonable to assume that it is based on the
Manα1-2Manα1-2Manα1-6Manα1-4GlcNα1-6PI struc-In contrast, the trypomastigote peak I material and all of
the epimastigote materials were at least 100-fold less ture common to all T.cruzi GPI/GIPL structures thus far
identiﬁed (De Lederkremer et al., 1991; Gu¨ther et al.,active in these assays. Although all of the data shown here
were obtained using IFN-γ-primed macrophges, similar 1992; Couto et al., 1993; Previato et al., 1995; Serrano
et al., 1995; Carreira et al., 1996). Monosaccharide com-results were obtained using unprimed macrophages except
that the levels of induction were lower, producing ~40, position analysis by GC–MS revealed the presence of
only mannose and galactose, in the ratio 4.0:2.5, suggesting20 and 10% of the TNF-α, IL-12 and NO levels shown
in Figures 1 and 2. that the trypomastigote GPI anchors are substituted with,
on average, 2.5 galactose residues.
It is worth noting that proteinase K, unlike PronasePuriﬁcation and analysis of the mucin GPI anchors
In order to establish the structural basis for the bioactivity (Ferguson et al., 1988), appears to be capable of cleaving
between the C-terminal amino acid and the ethanolamineof the trypomastigote versus the epimastigote peak II
mucins, these materials were digested with proteinase K, phosphate bridge. The removal of amino acids from the
GPI anchors was not complete, and some molecularand the GPI anchors of each repuriﬁed by octyl-Sepharose
chromatography. After pooling the myo-inositol-con- species containing aspartic acid were observed in the mass
spectra. Furthermore, amino acid sequencing of the GPItaining fractions, the puriﬁed GPI anchors were titrated
for NO- and cytokine-inducing activity alongside the intact fraction revealed Asp and a trace of Ile–Asp. These
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Fig. 2. Bioactivity and mass spectra of puriﬁed GPI anchors released from T.cruzi mucins. Samples were presented to 106 thioglycollate-elicited,
IFN-γ-primed, murine peritoneal macrophages and titrations of the TNF-α- (A), IL-12(p40)- (B) and NO- (C) inducing activities of intact
trypomastigote mucin (d), puriﬁed GPI released from trypomastigote mucin (s) and puriﬁed GPI released from epimastigote mucin (u) are shown.
The data shown in (A–C) are representative of four separate titration experiments. Each cytokine and NO determination was carried out in duplicate,
and the error bars (where visible) indicate the standard error of the mean. The puriﬁed trypomastigote GPI (D) and epimastigote GPI (E) fractions
were analysed by negative-ion ES-MS. The compositions corresponding to each [M-2H]2– pseudomolecular ion are indicated. Ions marked with
asterisks are [MNa-3H]2– pseudomolecular ions, and the underlined ions correspond to GPI anchors attached to Asp. EtNP, ethanolamine
phosphate; AEP, 2-aminoethylphosphonate; InsP, inositol-phosphate; AAG, alkylacylglycerol. The numbers following the AAG abbreviation
correspond to the chain length and degree of unsaturation of the alkyl/acyl chains. Note: m/z differences of 81 correspond to mass differences of 162
[equivalent to a hexose (Hex), i.e. mannose or galactose] because the charge state of the ions (z) is 2.
observations are consistent with the predicted amino acid The bioactive trypomastigote mucin GPI anchors
are free from Mycoplasma lipopeptidessequences of the T.cruzi mucins, many of which contain
a conserved IDGS sequence next to a C-terminal hydro- Mycoplasma lipopeptides are among the most potent
known proinﬂammatory microbial products (Mu¨hlradtphobic sequence (Salazar et al., 1996; Di Noia et al.,
1998; Freitas-Junior et al., 1998), such that D would et al., 1997, 1998). Since Mycoplasma are common tissue
culture contaminants, it was important to exclude thebe the predicted peptide cleavage/GPI attachment site
(Udenfriend and Kodukula, 1995). possibility of Mycoplasma lipopeptide contamination from
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TOF-MS) analysis of 10 pmol of the GPI preparation did
not reveal any peptides or lipopeptides under conditions
where 10 pmol of a synthetic MALP-2 were clearly visible
(Figure 3).
Epimastigote GPI-mucins and GIPLs from different
strains of T.cruzi are inactive and do not inhibit
the activity of trypomastigote GPI-mucins
To investigate whether the lack of cytokine and NO
induction by Y strain GPI-mucins and GIPLs was unique
to this strain of T.cruzi, GPI-mucins and GIPLs were
puriﬁed from CL and Tulahuen strains, and, together with
Y strain materials, tested at concentrations up to 400 nM
(Figure 4A). The chemical compositions of the epimastig-
ote GIPLs and GPI-mucin GPI anchors (released by
proteinase K) were analysed by ES-MS and ES-MS–
CID-MS, as described above, and the data are summarized
in Table II.
The trypomastigote GPI-mucins produced maximal NO,
TNF-α and IL-12 synthesis at the lowest concentration
used in this experiment (3.3 nM), and some reduction in
the synthesis of TNF-α and IL-12 was observed at 80
and 400 nM trypomastigote GPI-mucin. In contrast, the
epimastigote materials showed little or no bioactivity
across the whole concentration range. The ceramide-
containing GIPLs from Y, CL and Tulahuen strains were
particularly inactive in all of the assays, as was the CL
strain GPI-mucin containing an lyso-alkyl-PI moiety in
the GPI anchor. Only the alkylacyl-PI-containing Y strain
GPI-mucins and CL strain GIPLs showed signiﬁcant
activity: at 400 nM these materials produced ~30% of the
Fig. 3. Puriﬁed trypomastigote GPIs are free of lipopeptides. A sample NO response induced by 1 nM trypomastigote GPI-mucin
of 10 pmol of synthetic Mycoplasma lipopeptide (A) and 10 pmol of (Figure 4A).puriﬁed T.cruzi trypomastigote mucin GPI fraction (B) were analysed
To investigate whether the epimastigote fractions onlyby positive-ion MALDI-TOF under identical conditions. The absence
of ions in (B) reﬂects the absence of any lipopeptides or peptides in appeared to lack activity due to the presence of inhibitory
the preparation and the inability of GPIs to produce positive ions components, the induction of IL-12, TNF-α and NO by
under the conditions used. In (A), the ions at m/z 2136, 2158 and 2180 1 nM trypomastigote GPI-mucin was also measured afterare the [MH], [MNa] and [M-H2Na] ions of S-(2,3-bishexa-
pre-incubation with the puriﬁed epimastigote GPI-mucindecanoyloxypropyl)cysteine-GNNDESNISFKEK, respectively and the
minor ion at m/z 2152* is most probably the [MH] ion of the and GIPL fractions (Figure 4B). No inhibition of IL-12,
corresponding sulfoxide. The ions at lower m/z values may be due to TNF-α or NO synthesis was observed with 3.3 nM
degradation products.
epimastigote GPI-mucins and GIPLs. Although some
inhibition was observed at epimastigote GPI-mucin and
GIPL concentrations of 16 nM and above (rising to athe bioactive T.cruzi GPI preparations. As mentioned
above, Edman sequencing (ﬁve cycles) of the puriﬁed maximum of 30% inhibition at 400 nM), it seems unlikely
that the lack of activity in the epimastigote GPI-mucinstrypomastigote GPI preparation revealed only D and a
trace of I in the ﬁrst cycle, and only a trace of D in the and GIPLs is due to the presence of an inhibitory agent.
second cycle, consistent with D and ID linked to the GPI
ethanolamine phosphate bridge. No further residues were Discussiondetected in the third, fourth and ﬁfth cycles. In contrast,
ﬁve cycles of Edman sequencing of synthetic Mycoplasma The unsaturated fatty acid of the trypomastigote GPI
alkylacyl-PI moiety is likely to be important for bioactivityfermentans lipopeptide (MALP-2) produced the expected
XGNND sequence (Muhlradt et al., 1997) in good yield, since the trypomastigote peak I mucins, which appear to
be identical to the peak II mucins except that they containwhere X (an empty cycle) is due to the thioether
glycerolipid-modiﬁed N-terminal cysteine residue. Other mainly lyso-alkyl-PI moieties (Table I), are relatively
inactive. This is also consistent with the known alkaliproinﬂammatory Mycoplasma lipopeptides (e.g. those of
M.hyorhinis) have N-terminal sequences of XGQTD or lability of the trypomastigote mucin bioactivity (Camargo
et al., 1997a). The trypomastigote GPI PI moieties aloneXGQTN (Muhlradt et al., 1998). Thus, the lack of G in
the second cycle and the lack of any residues in the third, (isolated after deamination of the trypomastigote peak II
mucin) were inactive at concentrations up to 25 nM,fourth and ﬁfth Edman cycles of the T.cruzi trypomastigote
GPI fraction strongly suggested that the preparation was suggesting that other features of the intact GPI anchor are
also necessary for bioactivity. Although it is possible thatdevoid of contaminating Mycoplasma lipopeptides.
Finally, positive-ion matrix-assisted laser desorption the differences in the carbohydrate structures of the
epimastigote and trypomastigote GPIs are crucial forionization time-of-ﬂight mass spectrometry (MALDI-
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bioactivity, it is also conceivable that the precise structure
of the GPI anchor glycan may not be critical and that it
serves, in this context, to solubilize the unsaturated
alkylacyl-PI moiety to make it available to its macrophage
receptor. Despite considerable efforts, we were unable to
conﬁrm certain chemical (e.g. catalytic hydrogenation
and mild acid hydrolysis) and enzymatic (e.g. α- and
β-galactosidases) modiﬁcations to the trypomastigote GPI
fraction by ES-MS. This was due to the small amounts
of material available from trypomastigotes (Almeida et al.,
1994), which are non-dividing cells that are cultured by
the infection of mammalian cell monolayers (Andrews
and Colli, 1982). In the absence of mass spectrometric
conﬁrmation of the predicted modiﬁcations to trypo-
mastigote GPIs, the effects of these treatments on bio-
activity are inadmissible. Therefore, in the long term, we
plan to resolve the minimum structural features required
for bioactivity by chemical synthesis.
An important feature of the data presented here is the
extremely low concentration of the trypomastigote GPI
anchors required for cytokine induction. Previous work
using highly puriﬁed GPI material from T.brucei variant
surface glycoproteins has shown cytokine induction at
micromolar rather than sub-nanomolar concentrations
(Magez et al., 1998). Similarly, Schoﬁeld and colleagues
have estimated that their P.falciparum and T.brucei GPI
anchor preparations are active in the 0.1–10 μM range
(Tachado and Schoﬁeld, 1994; Schoﬁeld et al., 1996;
Tachado et al., 1996). These low speciﬁc activities are
similar to those observed here for the relatively inactive
T.cruzi epimastigote GIPLs and epimastigote mucin GPI
anchor structures, and one might question the physiological
relevance of effects using micromolar concentrations of
GPIs.
Dual requirements for the carbohydrate and lipid com-
ponents have been proposed to account for cytokine
induction by protozoal GPI anchors. Tachado et al. (1997)
suggest a receptor for the GPI glycan and the translocation
of the PI moiety to the cytoplasm to act as a second
messenger, whereas Magez et al. (1998) suggest the
involvement of two distinct receptors for the glycan and
lipid components of T.brucei-derived GPI anchors. In
contrast, we were unable to detect any cytokine or NO
induction using the puriﬁed PI component of the trypo-
mastigote GPI anchor, even when presented to macro-
phages at concentrations up to 25 nM (~1000-fold higher
than that required for the induction of TNF-α and IL-12Fig. 4. Bioactivities of Y, CL and Tulahuen strain epimastigote GPI-
by the intact GPI). Therefore, we suggest that intactmucins and GIPLs. (A) Titration of NO (top panels), TNF-α (middle
panels) and IL-12(p40) (bottom panels) induction by intact GPI- trypomastigote GPI anchors bind to some, as yet undeﬁned,
mucins or GIPLs puriﬁed from the epimastigote forms of Y, CL and macrophage receptor that leads to transmembrane signal-
Tulahuen (T) strains of T.cruzi. The partial structure and purity of each ling and subsequent transcription of the genes encodingglycoconjugate were evaluated by ES-MS and ES-MS–CID-MS
certain cytokines and inducible nitric oxide synthase. The(Table II); AAG, MAG and CER indicate the presence of
mechanism by which trypomastigote mucins might reachalkylacylglycerol, monoalkylglycerol or ceramide lipids in the PI
moieties of the GPI structures. Macrophages were primed with IFN-γ a putative macrophage receptor in vivo is unknown.
(100 U/ml) overnight and then stimulated with 3.3, 16, 80 and 400 nM However, the passive shedding from, and re-incorporation
epimastigote-derived glycoconjugate. As a positive control, Y strain into, cell plasma membranes by GPI-anchored proteins istrypomastigote GPI-mucin was used at the same concentrations.
a well known phenomenon, and mono-molecular, micellarTNF-α was measured in the macrophage culture supernatants 24 h
after stimulation, and IL-12(p40) and nitrite were measured 48 h after and micro-vesicular transport have all been discussed in
stimulation. Horizontal lines indicate the macrophage response to this context (reviewed in Ilangumaran et al., 1996; Medof
IFN-γ alone. (B) Inhibitory activities of the epimastigote GPI-mucins et al., 1996).
and GIPLs. Titration of the inhibition of NO (top panels), TNF-α In conclusion, we have established that highly puriﬁed(middle panels) and IL-12(p40) (bottom panels) induction by 1 nM
GPI anchors isolated from GPI-anchored mucins from onetrypomastigote GPI-mucin by pre-incubation (2 h) with epimastigote
GPI-mucins and GIPLs. life cycle stage (trypomastigote) of T.cruzi, and having
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Table II. Mucin- and GIPL-derived GPIs isolated from different strains of T.cruzi epimastigotes
Epimastigote GPI origina Major ion Molecular Proposed assignment for the GPI
strain speciesb mass (Da)
[M-2H]2– Glycan core Lipid component of the PI moiety
Y GIPLs 1038.3 2078.6 [Hex5-GlcN][AEP]2 CER, (C24:0)fatty acid-(C18:0)sphinganine
1046.5 2095.0 [Hex5-GlcN][EtNP][AEP] CER, (C24:0)fatty acid-(C18:0)sphinganine
1065.6 2133.2 [Hex6-GlcN][AEP] CER, (C24:0)fatty acid-(C18:0)sphinganine
mucins 908.9 1819.8 [Hex4-GlcN][AEP]2 AAG, (C16:0)alkyl-(C16:0)acylglycerol
916.8 1835.6 [Hex4-GlcN][EtNP][AEP] AAG, (C16:0)alkyl-(C16:0)acylglycerol
997.9 1997.8 [Hex5-GlcN][EtNP][AEP] AAG, (C16:0)alkyl-(C16:0)acylglycerol
CL GIPLs 989.8 1981.6 [Hex5-GlcN][AEP]2 AAG, (C16:0)alkyl-(C16:0)acylglycerol
997.8 1997.6 [Hex5-GlcN][EtNP][AEP] AAG, (C16:0)alkyl-(C16:0)acylglycerol
1017.1 2036.2 [Hex6-GlcN][AEP] AAG, (C16:0)alkyl-(C16:0)acylglycerol
1038.3 2078.6 [Hex5-GlcN][AEP]2 CER, (C24:0)fatty acid-(C18:0)sphinganine
1046.5 2095.0 [Hex5-GlcN][EtNP][AEP] CER, (C24:0)fatty acid-(C18:0)sphinganine
1065.6 2133.2 [Hex6-GlcN][AEP] CER, (C24:0)fatty acid-(C18:0)sphinganine
mucins 789.8c 1581.6 [Hex4-GlcN][AEP]2 MAG, (C16:0)mono(lyso)alkyl-glycerol
797.8c 1597.6 [Hex4-GlcN][EtNP][AEP] MAG, (C16:0)mono(lyso)alkyl-glycerol
Tulahuen GIPLs 908.9 1819.8 [Hex4-GlcN][AEP]2 AAG, (C16:0)alkyl-(C16:0)acylglycerol
965.2 1932.4 [Hex4-GlcN][EtNP][AEP] CER, (C24:0)fatty acid-(C18:0)sphinganine
mucins 916.8 1835.6 [Hex4-GlcN][EtNP][AEP] AAG, (C16:0)alkyl-(C16:0)acylglycerol
aThe GPI anchor was obtained after proteinase K digestion of the puriﬁed mucin as described in Materials and methods.
bThe most abundant GPI species within the mixture is underlined.
cThe monoalkyglycerol-PI species was obtained from alkylacylglycerol-PI (m/z 909 or 917) species after alkaline hydrolysis (6 M ammonium
hydroxide, 37°C, 1 h), to remove the fatty acid at the sn-2 position of the glycerol, followed by puriﬁcation on an octyl-Sepharose column.
CER, ceramide; AAG, alkylacylglycerol; MAG, monoalkylglycerol.
unique structural features (Figure 5), are extremely potent genesis of cardiac and/or oesophagus and/or colon path-
ology observed during chronic Chagas’ disease.inducers of NO, IL-12 and TNF-α when presented to
macrophages. On a molar basis, this material is at least
as active as bacterial lipopolysaccharide (LPS) (Camargo Materials and methods
et al., 1997a) and Mycoplasma lipopeptides (Mu¨hlradt
Animalset al., 1997, 1998), establishing it as one of the most
Male LPS-hyporesponsive C3H/HeJ mice (FIOCRUZ, Rio de Janeiro),potent microbial proinﬂammatory molecules known. Since
6–7 weeks old, were used as the source of inﬂammatory macrophages.the NO and cytokine induction experiments were per-
formed with LPS-hyporesponsive (C3H/HeJ) macro- Mammalian cells and parasites
phages, contamination of the T.cruzi GPIs with bacterial Green monkey kidney-derived LLC-MK2 cells (American Type Culture
Collection, Rockville, MD) were maintained at 37°C in Dulbecco’sLPS can be ruled out as an explanation for their potency.
modiﬁed Eagle’s medium (DMEM) supplemented with 10% heat-Furthermore, contamination with Mycoplasma lipopeptide inactivated fetal calf serum (FCS), 2 mM L-glutamine, 20 μg/ml
can be ruled out because: (i) MALDI-TOF-MS analysis gentamicin sulfate, 0.3% sodium bicarbonate and 5% CO2. Trypomastig-
of the GPI preparation did not reveal any peptides or ote forms of T.cruzi (Y strain) were obtained from the supernatant of
LLC-MK2 cells 6–8 days after primary infection with 10 trypomastigoteslipopeptides under conditions where MALP-2 was clearly
per cell (Andrews and Colli, 1982). Parasites were harvested daily byvisible; (ii) Edman peptide sequencing of the GPI prepar-
centrifugation (700 g, 15 min, 4°C), washed three times in ice-cold
ations did not reveal any Mycoplasma lipopeptide-related phosphate-buffered saline (PBS) pH 7.4 and kept at –70°C. Epimastigote
amino acid sequences; and (iii) N-acetylation of MALP-2 forms of T.cruzi (Y strain) were grown at 28°C in cell-free liver infusion
tryptose (LIT) medium supplemented with 10% heat-inactivated FCSabolished its NO-inducing activity, as expected (Mu¨hlradt
(Camargo, 1964).et al., 1998), but had no signiﬁcant effect on the NO-
inducing activity of trypomastigote mucin (data not Puriﬁcation of epimastigote and trypomastigote mucins
shown). Trypanosoma cruzi mucin-like glycoproteins from trypomastigote and
epimastigote forms (Y strain) were puriﬁed using a slight modiﬁcationFinally, it is possible that T.cruzi trypomastigote GPI
of previous procedures (Almeida et al., 1994; Serrano et al., 1995). Inanchors may be crucial for the potentiation of innate
brief, parasite pellets containing in total 1.5  1010 trypomastigotes and
cellular immunity, which controls the parasite population 2.0  1010 epimastigotes were freeze-dried and sequentially delipidated
and drives T-cell development during the early stages of with 10 vols of each of the following solvent mixtures: (i) chloroform:
methanol (2:1, v/v); (ii) chloroform:methanol (1:1, v/v); (iii) chloroform:infection (Aliberti et al., 1996; Fearon and Locksley,
methanol (1:2, v/v); and (iv) chloroform:methanol:water (1:2:0.8, by1996; Brener and Gazzinelli, 1997). Moreover, despite the
vol.). Between each extraction, insoluble cell debris was separated from
controversy about the mechanism of immunopathogenesis the organic phase by centrifugation (1500 g, 15 min, 10°C). The ﬁnal
of Chagas’ disease (Brener and Gazzinelli, 1997), recent delipidated parasite debris was dried under N2 and extracted three times
with 10 vols of butan-1-ol-saturated water (9% butan-1-ol) (4 h, at roomstudies suggest that T.cruzi parasites are physically present
temperature). The resulting extracts were combined, dried under vacuum,at the sites of inﬂammation (Higuchi et al., 1993; Jones
dissolved in 5% propan-1-ol, 0.1 M ammonium acetate (buffer A),
et al., 1993; Vago et al., 1996). Thus, the local release
and applied onto an octyl-Sepharose (Amersham-Pharmacia Biotech,
of trypomastigote GPI-anchored mucins could play an Uppsala, Sweden) column (1.0 10 cm) at a ﬂow rate of 4 ml/h, at
room temperature. After washing with 10 vols of buffer A and 10 volsimportant role in parasite-elicited inﬂammation and the
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SpeedVac, redissolved in 90 μl of 10 mM Tris–HCl pH 7.8, 1 mM
CaCl2, and incubated with 10 μl of proteinase K (5 mg/ml; Promega,
Madison, WI) for 16 h at 37°C. The incubation was terminated by
heating at 100°C for 5 min. The sample was then extracted three times
with 200 μl of water-saturated butan-1-ol (91% butan-1-ol). The released
GPI moiety was recovered in the butanolic phases, which were combined
and washed further (three times) with water to remove any residual
glycopeptides and/or salts. The sample was puriﬁed further on an octyl-
Sepharose column as described above. Five microlitres of each 1 ml
fraction were used for myo-inositol and ES-MS analyses.
Myo-inositol and monosaccharide analyses
Native mucins and isolated GPIs were quantiﬁed by their myo-inositol
content using selective ion monitoring at m/z 305, 307, 318 and 321
of trimethylsilyl derivatives (Ferguson, 1993). Monosaccharides were
quantiﬁed as methyl-glycoside-trimethylsilyl derivatives as decribed in
Ferguson (1993), except that selected ion-monitoring GC–MS (for m/z
173, 204, 217, 272, 298, 305 and 318) was used.
Mass spectrometry of GPI fractions
Trypomastigote and epimastigote GPI samples (2.5 and 4.9 pmol/μl,
respectively) were introduced into the Micromass Quattro electrospray
source (Micromass, Manchester, UK) at 5 μl/min in 50% propan-1-ol,
0.2% formic acid. Negative ion spectra were collected. The capillary
voltage was 2.3 kV, the cone voltage was 40 V and cone/skimmer offset
was 5 V.
Positive-ion MALDI-TOF spectra of GPIs and synthetic MALP-2
lipopeptide were recorded in linear mode using a PerSeptive Biosystems
Voyager DE-STR spectrometer and α-cyano-4-hydroxycinnamic acid as
the matrix.
Preparation and analysis of PI components
Epimastigote and trypomastigote mucins (peaks I and II; 4.8 and 1.8 nmol
with respect to myo-inositol content, respectively) were dissolved in
200 μl of water and extracted three times with 200 μl of butan-1-olFig. 5. Comparison of active and representative relatively inactive
saturated with water to remove any contaminating lipids. The aqueousT.cruzi GPI structures. The epimastigote mucin (peak II) GPI structure phases were dried and redissolved in 40 μl of 0.1 M sodium acetate(Previato et al., 1995; Serrano et al., 1995) is consistent with the buffer pH 4.0, and deaminated by three additions (at 1 h intervals) ofES-MS spectrum in Figure 2E and the ES-MS analysis of the PI 10 μl of 0.5 M sodium nitrite, at 60°C. The samples were mixed withmoiety (Table I). Only the identity and linkage position of the 250 μl of 9% butan-1-ol and the released PIs were recovered by threeadditional hexose residue (Hex) are unknown (Previato et al., 1995;
extractions with 250 μl of butan-1-ol saturated with water. The combinedSerrano et al., 1995). The proposed trypomastigote peak II GPI butanolic phases were dried, redissolved in 200 μl of chloroform:meth-structure is based on the epimastigote structure and is consistent with
anol:5 mM ammonium acetate (10:10:3, by vol.) and introduced intothe ES-MS spectrum in Figure 2D, the GC–MS monosaccharide
the electrospray source at 5 μl/min. Negative-ion spectra were collected.analysis and the ES-MS analysis of the PI moiety (Table I). The
The capillary voltage was 2.5 kV, the cone voltage was 60 V anddotted line indicates that the linkage position(s) of the uncharacterized
cone/skimmer offset was 5 V. Collision-induced dissociation (CID)galactose substituents (Gal0–4) is unknown. The types and proportions experiments were performed using 2.5 10–3 torr argon and an accelerat-of the major alkyl and acyl (fatty acid) chains are indicated. The exact ing voltage of 50 V. Epimastigote GIPLs (peak III; 5.6 nmol myo-inositol)isomer of the C18:2 fatty acid (shown here as linoleic acid) has not
were also submitted (without pre-extraction with butan-1-ol) to nitrousbeen determined. The ceramide-containing epimastigote (peak III) deamination and PI analysis as described above.GIPL structure is taken from De Lederkremer et al. (1991) and
Previato et al. (1990), and is consistent with an ES-MS spectrum of N-acetylation
this fraction (data not shown) and the ES-MS analysis of the PI Samples were N-acetylated at 0°C in 40 μl of 1 M ammonia by two
moiety (Table I).
additions of 1 μl of acetic anhydride, 10 min apart. After 30 min at
room temperature, 160 μl of water were added and the samples were
of 5% propan-1-ol, the column was eluted using a propan-1-ol gradient desalted by freeze–drying twice.(5–60%), at a ﬂow rate of 12 ml/h. Eighty 1 ml fractions were collected.
For detection of the trypomastigote mucin-containing fractions, 2–5 μl Macrophage culture
aliquots of each fraction were used for Western blotting and chemi- C3H/HeJ mice were inoculated intraperitoneally with 2 ml of 3%
luminescent-enzyme-linked immunosorbent assay (CL-ELISA) using thioglycollate. Four days later, the elicited peritoneal exudate cells were
anti-α-galactosyl (anti-Gal) antibodies puriﬁed from chronic Chagas’ harvested in cold FCS-free DMEM (Life Technologies, Grand Island,
disease patients (Almeida et al., 1991, 1994). Epimastigote and trypo- NY) and centrifuged at 700 g for 10 min at 4°C. Cells were resuspended
mastigote mucins were also detected by silver staining of the SDS–poly- in DMEM supplemented with 5% heat-inactivated FCS, 2 mM
acrylamide gel (Camargo et al., 1997a). GIPLs were identiﬁed by ES-MS L-glutamine and 40 μg/ml gentamicin sulfate (MacMed), at a ﬁnal
analysis (see below) of 5 μl aliquots of each octyl-Sepharose-puriﬁed
concentration of 2  106/ml, and 0.1 ml aliquots were transferred intofraction. The alkylacylglycerol- and ceramide-containing GIPLs were
wells of a 96-well plate. Cells were allowed to adhere at 37°C and 5%
enriched in different fractions of peak III, with the former eluting slightly CO2 for 3 h, and were then washed once with serum-free DMEM. Oneearlier than the latter. Note: the appearance of substantial amounts of hundred microlitres of MacMed were added to the macrophage culturesGIPLs in the 9% butan-1-ol fraction was a reproducible phenomenon in a ﬁnal volume of 200 μl/well. Puriﬁed parasite preparations werethat shows that the T.cruzi GIPLs (particularly the alkylacylglycerol-
incubated with macrophages in the presence or absence of IFN-γcontaining species) are not extracted quantitatively into chloroform: (100 U/ml; Genzyme Corp., Cambridge, MA). Aliquots of the supernatantmethanol:water (1:2:0.8, by vol.). This is different from the situation in (50 and 100 μl) were collected after 24 and 48 h of culture for TNF-αother trypanosomatids, such as the Leishmania, and suggests that the
and IL-10 as well as IL-12(p40) measurements, respectively (CamargoT.cruzi GIPLs and mucins may co-extract as a complex.
et al., 1997a,b).
Isolation of the epimastigote and trypomastigote mucin
Cytokine and nitric oxide measurementsGPIs
All samples were analysed in duplicate. TNF-α was quantiﬁed employingBrieﬂy, ~1 and 3 nmol (with respect to myo-inositol content) of
trypomastigote and epimastigote mucins, respectively, were dried in a an ELISA kit (Genzyme, Duoset kit). IL-12(p40) was assayed by
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sandwich ELISA, as described previously (Camargo et al., 1997a). the glycan of lipopeptidophosphoglycan from Trypanosoma cruzi
epimastigotes. J. Biol. Chem., 266, 23670–23675.C17.1.5 (1510) rat monoclonal antibody (mAb) (5 μg/ml) and biotinylated
C 15.6 (676) rat mAb (Genzyme) (1:750 dilution) were used for capture De Lederkremer,R.M., Lima,C.E., Ramirez,M.I., Gonc¸alvez,M.F. and
Colli,W. (1993) Hexadecylpalmitoylglycerol or ceramide is linked toand detection of bound IL-12, respectively. Recombinant murine IL-12
was used as standard. The nitrite concentration in the culture supernatants similar glycophosphoinositol anchor-like structures in Trypanosoma
cruzi. Eur. J. Biochem., 218, 929–936.was assayed in a 98-well microplate by mixing 0.1 ml of culture
supernatant with 0.1 ml of Griess reagent. The absorbance at 540 nm Di Noia,J.M., D’Orso,I., Aslund,L., Sanchez,D.O. and Frasch,A.C.C.
(1998) The Trypanosoma cruzi mucin family is transcribed fromwas read 10 min later and the NO2 concentration was determined
by reference to a standard curve of 1–100 mM NaNO2 (Camargo hundreds of genes having hypervariable regions. J. Biol. Chem., 273,
10843–10850.et al., 1997b).
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